Dibenzyline

Dibenzyline

(dĭ-bĕn′zĭ-lēn′)
A trademark for the drug phenoxybenzamine hydrochloride.

Dibenzyline

a trademark for an alpha1 receptor blocker (phenoxybenzamine hydrochloride).
Mentioned in ?
References in periodicals archive ?
consists of a portfolio of branded products and authorized generic contracts, including branded products such as Nilandron, for the treatment of metastatic prostate cancer; Dibenzyline, for the treatment of pheochromocytoma; Lanoxin, for the treatment of mild-to-moderate heart failure and atrial fibrillation; Plaquenil, for the treatment of lupus and rheumatoid arthritis, Donnatal for the treatment of irritable bowel syndrome and Zonegran (zonisamide) for treatment of partial seizures in adults with epilepsy.
Alpha blockers (including Dibenzyline and Hytrin) and antispasmodic medicines (including Ditropan and Pro-Banthene) are sometimes prescribed to improve bladder emptying.
Key products are Nilandron, for the treatment of metastatic prostate cancer; Dibenzyline, for the treatment of pheochromocytoma; Lanoxin, for the treatment of mild-to-moderate heart failure and atrial fibrillation; and, Plaquenil, for the treatment of lupus and rheumatoid arthritis.
consists of 23 products including Nilandron, for the treatment of metastatic prostate cancer; Dibenzyline, for the treatment of pheochromocytoma; Lanoxin, for the treatment of mild-to-moderate heart failure and atrial fibrillation; Plaquenil, for the treatment of lupus and rheumatoid arthritis, Donnatal for the treatment of irritable bowel syndrome and Zonegran (zonisamide) for treatment of partial seizures in adults with epilepsy.
Prasco intends to launch DIBENZYLINE upon first generic entrant
As part of the agreement, Prasco, LLC is prepared to immediately market the authorized generic of DIBENZYLINE (phenoxybenzamine hydrochloride capsules, USP), upon the first U.